Dr. Talukder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1919 Old Spanish Trail
Houston, TX 77030
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2020 - 2023
Baylor College of MedicineResidency, Internal Medicine, 2016 - 2019
The University of Texas Health Science Center at San AntonioClass of 2016
Certifications & Licensure
TX State Medical License 2018 - 2026
WA State Medical License 2022 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data.Tanya Jindal, Cindy Jiang, Omar Alhalabi, Amanda Nizam, Charles Nguyen
European Urology Oncology. 2024-12-20 - Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint I...Dimitra Rafailia Bakaloudi, Rafee Talukder, Dimitrios Makrakis, Leonidas Diamantopoulos, Thomas Enright
Clinical Genitourinary Cancer. 2024-12-01 - Long-term survival following anti-PD-(L)1 monotherapy in advanced urothelial cancer and an assessment of potential prognostic clinical factors: a multicentre observati...Chantal F Stockem, Sarah M H Einerhand, Isabel Miras Rodríguez, Youssra Salhi, Esther Pérez
BJC Reports. 2024-10-23
Abstracts/Posters
- Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk StratificationRafee Talukder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during Induction61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Predictive Factors for Complete Remission and Survival in AML Patients Failing to Achieve Adequate Bone Marrow Day 14 Blast Eradication2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
